Litcius/Paper detail

Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium

Yoichiro Tohi, Takuma Kato, Hideo Fukuhara, Keita Kobayashi, Shin Ohira, Kenichiro Ikeda, Kei Daizumoto, Satoshi Katayama, Ryutaro Shimizu, Kenichi Nishimura, Taichi Nagami, Yushi Hayashida, Hiromi Hirama, Atsushi Takamoto, Teruki Dainichi, Mikio Sugimoto, Keiji Inoue, Shinkuro Yamamoto, Hideyasu Matsuyama, Atsushi Nagai, Nobuyuki Hinata, Hiro‐omi Kanayama, Yasutomo Nasu, Atsushi Takenaka, Takashi Saika, Koichiro Wada, Yoichiro Tohi, Takuma Kato, Hideo Fukuhara, Keita Kobayashi, Shin Ohira, Kenichiro Ikeda, Kei Daizumoto, Satoshi Katayama, Ryutaro Shimizu, Kenichi Nishimura, Taichi Nagami, Atsushi Takamoto, Mikio Sugimoto

2022International Journal of Clinical Oncology26 citationsDOI

Topics & Concepts

Adverse effectMedicineCommon Terminology Criteria for Adverse EventsIncidence (geometry)DiscontinuationSkin cancerInternal medicineProstate cancerHazard ratioSurgeryCancerConfidence intervalPhysicsOpticsProstate Cancer Treatment and ResearchChemotherapy-related skin toxicityProstate Cancer Diagnosis and Treatment
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium | Litcius